Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbaz...

Por Propper, D J, Braybrooke, J P, Levitt, N C, O'Byrne, K, Christodoulos, K, Han, C, Talbot, D C, Ganesan, T S, Harris, A L
Publicado em 2000

Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer

Por Levitt, N C, Propper, D J, Madhusudan, S, Braybrooke, J P, Echeta, C, te Poele, R, Davies, S L, Flanagan, E, Hickson, I D, Joel, S, Ganesan, T S
Publicado em 2005

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer

Por Khan, O A, Ranson, M, Michael, M, Olver, I, Levitt, N C, Mortimer, P, Watson, A J, Margison, G P, Midgley, R, Middleton, M R
Publicado em 2008

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer

Por Khan, O A, Ranson, M, Michael, M, Olver, I, Levitt, N C, Mortimer, P, Watson, A J, Margison, G P, Midgley, R, Middleton, M R
Publicado em 2009

Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer

Por Propper, D J, Levitt, N C, O'Byrne, K, Braybrooke, J P, Talbot, D C, Ganesan, T S, Thompson, C H, Rajagopalan, B, Littlewood, T J, Dixon, R M, Harris, A L
Publicado em 2000